SCHEMBL23273242

SCHEMBL23273242

CC(NC(=O)C(CO)NC(=O)C(CCCNC(=N)N)NC(=O)C(CCCNC(=N)N)NC(=O)CN)C(=O)NC(CCC(=O)O)C(=O)NC(CC(=O)O)C(=O)NC(CCC(=O)O)C(=O)NC(CC(N)=O)C(=O)O

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TFPI P10646 1/20 0.44
▸ NPY5R Q15761 3/20 0.43
▸ NPY1R P25929 2/20 0.43
▸ NPY4R P50391 2/20 0.43
▸ VIPR1 P32241 2/20 0.41
▸ GRIN2D O15399 1/20 0.41
▸ GRIN3B O60391 1/20 0.41
▸ GRIN1 Q05586 1/20 0.41
▸ GRIN2A Q12879 1/20 0.41
▸ GRIN2B Q13224 1/20 0.41
▸ GRIN2C Q14957 1/20 0.41
▸ GRIN3A Q8TCU5 1/20 0.41
▸ VIPR2 P41587 2/20 0.40
▸ NMT2 O60551 1/20 0.39
▸ NMT1 P30419 1/20 0.39
▸ KISS1R Q969F8 1/20 0.39
▸ OPRL1 P41146 2/20 0.39
▸ EPHA2 P29317 1/20 0.39
▸ SIRT2 Q8IXJ6 1/20 0.38
▸ SIRT5 Q9NXA8 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23273237 0.90 BACE1 (0.45) TFPINPY5RNPY1RNPY4RVIPR1
SCHEMBL20764543 0.89 BACE1 (0.46) NPY5RNPY1RNPY4RVIPR1
SCHEMBL29638076 0.89 NPY4R (0.42) TFPINPY5RNPY1RNPY4RNMT2
SCHEMBL29769750 0.88 NPY5R (0.47) TFPINPY5RNPY1RNPY4R
SCHEMBL30406054 0.88 GNPAT (0.42) NPY5RNPY1RNPY4RSIRT5
SCHEMBL30918787 0.88 TFPI (0.43) TFPINPY5RNPY1RNPY4RNMT2
SCHEMBL30974313 0.87 NMT1 (0.43) NPY5RNPY1RNPY4RNMT2NMT1
SCHEMBL29630561 0.87 NMT1 (0.43) NPY5RNPY1RNPY4RNMT2NMT1
SCHEMBL30930537 0.86 TFPI (0.47) TFPINPY5RNPY1RNPY4RVIPR1
SCHEMBL30069087 0.86 TFPI (0.53) TFPINPY5RNPY1RNPY4RGRIN2D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11911451-B2 Composition of tumor-associated proliferative peptides and related anti-cancer immunogen for the treatment of lung cancers and other cancers ImmuLogix Ltd (US) 2024-02-27 — — US disclosed
US-20210121546-A1 COMPOSITION OF TUMOR-ASSOCIATED PROLIFERATIVE PEPTIDES AND RELATED ANTI-CANCER IMMUNOGEN FOR THE TREATMENT OF LUNG CANCERS AND OTHER CANCERS ImmuLogix Ltd (US) 2021-04-29 — — US disclosed
Send feedback